Literature DB >> 12703973

Covalent binding of leukotriene A4 to DNA and RNA.

Joseph A Hankin1, David N M Jones, Robert C Murphy.   

Abstract

Leukotriene A(4) (LTA(4)) is a highly reactive electrophilic intermediate formed during the biosynthesis of the lipid mediators leukotriene B(4) and leukotriene C(4). Deoxynucleosides were found to react as nucleophiles with LTA(4) in aqueous solutions as assessed by UV spectroscopy and electrospray ionization mass spectrometry. Aqueous solutions of native DNA and RNA were also found to react with LTA(4) as assessed by mass spectrometric analysis of the constituent nucleosides derived from enzymatic hydrolysis of the nucleic acids. The most abundant adducts were observed for guanine- and adenine-containing deoxynucleosides and nucleosides. At neutral pH, these reactions led to an overall modification of deoxyguanosine/guanosine residues in DNA and RNA at 15 +/- 1 adducts/10(7) bases and 230 +/- 20 adducts/10(7) bases, respectively, determined by quantitative assay using stable isotope-labeled LTA(4)-nucleoside adduct. An estimation of the relative reactivity of LTA(4) with each of the purine and pyrimidine bases in DNA and RNA was carried out by comparisons of the mass spectral ion abundance of the different adducts (LTA(4)-dAdo, LTA(4)-dCyd, LTA(4)-Thd, LTA(4)-Ado, LTA(4)-Cyd, and LTA(4)-Urd) to the ion signal of known amounts of LTA(4)-dGuo and LTA(4)-Guo standards. The data were corrected for different mass spectrometric response factors that were experimentally determined for each adduct product. The structures of the two most abundant LTA(4)-Guo products were determined by NMR, UV spectroscopy, and mass spectrometry to be 5-hydroxy,12-[Guo-N(2)-yl]-6,8,11,14-eicosatetraenoic acid. Stimulation of human neutrophils with calcium ionophore led to the covalent modification of DNA within the cell as determined by mass spectrometric analysis of lipophilic nucleosides obtained after hydrolysis of extracted DNA. These observations, combined with the intracellular site of 5-lipoxygenase translocation and LTA(4) biosynthesis at the nuclear envelope, suggest that LTA(4) may have access to DNA and RNA within cells and furthermore modify nucleic acids in situ following the activation of 5-lipoxygenase and initiation of LTA(4) biosynthesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12703973     DOI: 10.1021/tx034018+

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  6 in total

Review 1.  Cyclooxygenase- and lipoxygenase-mediated DNA damage.

Authors:  N Speed; I A Blair
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

2.  Characterization of a lipid hydroperoxide-derived RNA adduct in rat intestinal epithelial cells.

Authors:  Peijuan Zhu; Seon Hwa Lee; Suzanne Wehrli; Ian A Blair
Journal:  Chem Res Toxicol       Date:  2006-06       Impact factor: 3.739

3.  Covalent adducts arising from the decomposition products of lipid hydroperoxides in the presence of cytochrome c.

Authors:  Michelle V Williams; John S Wishnok; Steven R Tannenbaum
Journal:  Chem Res Toxicol       Date:  2007-04-04       Impact factor: 3.739

4.  Knock-out of 5-lipoxygenase in overexpressing tumor cells-consequences on gene expression and cellular function.

Authors:  Hannah Weisser; Tamara Göbel; G Melissa Krishnathas; Marius Kreiß; Carlo Angioni; Duran Sürün; Dominique Thomas; Tobias Schmid; Ann-Kathrin Häfner; Astrid S Kahnt
Journal:  Cancer Gene Ther       Date:  2022-09-16       Impact factor: 5.854

5.  Capturing proteins that bind polyunsaturated fatty acids: demonstration using arachidonic acid and eicosanoids.

Authors:  Thomas G Brock
Journal:  Lipids       Date:  2007-12-15       Impact factor: 1.880

Review 6.  Cell signalling by reactive lipid species: new concepts and molecular mechanisms.

Authors:  Ashlee Higdon; Anne R Diers; Joo Yeun Oh; Aimee Landar; Victor M Darley-Usmar
Journal:  Biochem J       Date:  2012-03-15       Impact factor: 3.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.